AstraZeneca continues to grow footprint in China

• Published date: 04 November 2021
• Publication title: Shanghai Daily

s AstraZeneca returns to the China International Import Expo, it is seeking to help further expand the influence of the important event and contribute to building up an integrated healthcare service ecosystem.

This year, with a total of 1,100 square meters of exhibition space themed "Leaping into a new horizon, co-creating a new ecosystem," AstraZeneca is not only focusing on its own innovative products and solutions but is also placing significant emphasis on partnership and the industry as a whole.

It's also been actively responding to the country's call for the adoption of the latest medicines and treatments on a trial basis at the Boao Lecheng pilot zone of international medical tourism.

straZeneca China has increasingly shown its strategic importance to the company in terms of scientific research and development, production and operation, and commercial innovation.

In early October, AstraZeneca unveiled its upgraded RandD China Center located in Jing'an District, the Shanghai International Life Science Innovation Campus, and the Medical Healthcare AI Innovation Center, serving as the latest milestone in AstraZeneca's expanding footprint in the country.

"The CIIE is undoubtedly an incomparable platform for enterprises to carry out government-enterprise communication, exchange, and cooperation. It also reflects the government's strong determination to open up to the outside world at a higher level and the mindset as a responsible large country in the world," said Leon Wang, executive vice-president, International and China president of AstraZeneca.

"The CIIE is an indispensable platform for us to showcase and to negotiate with collaborators, and it is now also an important chance to exemplify these practices," Wang said.

Through collaboration with government, industry, academia, research institutes, medical institutions, and investment with other cross-sector partners, AstraZeneca will unveil a multi-level healthcare innovation ecosystem.

n additional 100-square-meter regional biopharmaceutical industry cooperation booth is set up to facilitate investment, roadshows, negotiations, and other events to boost regional economies and innovative development.

The area, comprised of an exhibition zone, activity zone, negotiation zone, and other industrial cooperation and exchange sections, will host a wide range of industrial recommendation activities, exchanges, negotiations, and innovative enterprise roadshows.

Leveraging its extensive platform and expansive reach as a...